Chase AIPricingFAQs
Display currency
Loading news…

Paragon Bioservices

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Baltimore, Maryland, United States Founded 1990 251-500 employees For Profit

Founded in 1990, Paragon Bioservices is a CDMO whose focus is complex biopharmaceuticals (AAV, oncolytic virus, next-generation vaccines).

Paragon Bioservices was acquired by Catalent Pharma Solutions in 2019 for $1B.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
23

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
Active products
7
IT spend
$9M

Company Info

Founded
1990
Employees
251-500
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
16
Events
1
HQ
Baltimore, Maryland, United States
Region
Greater Baltimore-Maryland Area, East Coast, Southern US
Exit date
Apr 14, 2019
Closed
Aug 7, 2014

Signals & Scores

Heat score
Low
Trend (7d)
0
Trend (30d)
-0.5
Trend (90d)
1.1

Key People at Paragon Bioservices

Chief Financial Officer
23
professional contacts at Paragon Bioservices
Contact execs at Paragon Bioservices

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Paragon Bioservices

Loading news…

FAQs about Paragon Bioservices

People who checked this page also checked these

Browse the full Acquirezy directory.
Paragon Bioservices - Company Profile, Full Acquisitions List, Funding and Investments